Molecular Basis of Juvenile Myelomonocytic Leukemia

Overview

Journal Haematologica

Specialty Hematology

Date 2010 Feb 9

PMID 20139388

Citations 20

Authors

Andrica C H de Vries

C Michael Zwaan

Marry M van den Heuvel-Eibrink

Affiliations

Soon will be listed here.

Citing Articles

Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study.

Peng Z, Gao J, Huang L, He Y, Tang H, Zong S Front Immunol. 2024; 15:1426640.

PMID: 39253078 PMC: 11381242. DOI: 10.3389/fimmu.2024.1426640.

Epigenetic Profiling of Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape.

Sinha R, Dvorak M, Ganesan A, Kalesinskas L, Niemeyer C, Flotho C Cancers (Basel). 2023; 15(21).

PMID: 37958378 PMC: 10650722. DOI: 10.3390/cancers15215204.

Potential value of high-throughput single-cell DNA sequencing of Juvenile myelomonocytic leukemia: report of two cases.

Volchkov E, Khozyainova A, Gurzhikhanova M, Larionova I, Matveev V, Evseev D NPJ Syst Biol Appl. 2023; 9(1):41.

PMID: 37684264 PMC: 10491583. DOI: 10.1038/s41540-023-00303-7.

Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.

Pasupuleti S, Chao K, Ramdas B, Kanumuri R, Palam L, Liu S Mol Ther. 2023; 31(4):986-1001.

PMID: 36739480 PMC: 10124140. DOI: 10.1016/j.ymthe.2023.01.030.

Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells.

Ramdas B, Yuen L, Palam L, Patel R, Pasupuleti S, Jideonwo V Mol Ther. 2022; 30(7):2505-2521.

PMID: 35443935 PMC: 9263321. DOI: 10.1016/j.ymthe.2022.04.009.

References

Hasle H, Wadsworth L, Massing B, McBride M, Schultz K . A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol. 1999; 106(4):1027-32. DOI: 10.1046/j.1365-2141.1999.01645.x. View

Tartaglia M, Niemeyer C, Fragale A, Song X, Buechner J, Jung A . Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003; 34(2):148-50. DOI: 10.1038/ng1156. View

Johan M, Bowen D, Frew M, Goodeve A, Reilly J . Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol. 2005; 129(1):60-5. DOI: 10.1111/j.1365-2141.2005.05412.x. View

Schmidt M, Dikic I . The Cbl interactome and its functions. Nat Rev Mol Cell Biol. 2005; 6(12):907-18. DOI: 10.1038/nrm1762. View

de Vries A, Stam R, Schneider P, Niemeyer C, van Wering E, Haas O . Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia. Haematologica. 2007; 92(11):1557-60. DOI: 10.3324/haematol.11201. View

Steinemann D, Arning L, Praulich I, Stuhrmann M, Hasle H, Stary J . Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica. 2009; 95(2):320-3. PMC: 2817036. DOI: 10.3324/haematol.2009.010355. View

Loh M, Sakai D, Flotho C, Kang M, Fliegauf M, Archambeault S . Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood. 2009; 114(9):1859-63. PMC: 2738571. DOI: 10.1182/blood-2009-01-198416. View

. Syndromes run together in the RAS pathway. Nat Genet. 2006; 38(3):267. DOI: 10.1038/ng0306-267. View

Fukuda M, Horibe K, Miyajima Y, Matsumoto K, Nagashima M . Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome. J Pediatr Hematol Oncol. 1997; 19(2):177-9. DOI: 10.1097/00043426-199703000-00019. View

10.

Kratz C, Niemeyer C, Castleberry R, Cetin M, Bergstrasser E, Emanuel P . The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood. 2005; 106(6):2183-5. PMC: 1895140. DOI: 10.1182/blood-2005-02-0531. View

11.

Chan R, Cooper T, Kratz C, Weiss B, Loh M . Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res. 2008; 33(3):355-62. PMC: 2692866. DOI: 10.1016/j.leukres.2008.08.022. View

12.

Furlan I, Batz C, Flotho C, Mohr B, Lubbert M, Suttorp M . Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood. 2009; 113(12):2867-8. DOI: 10.1182/blood-2008-12-195693. View

13.

Niemeyer C, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U . Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood. 1997; 89(10):3534-43. View

14.

Silvio F, Carlo L, Elena B, Nicoletta B, Daniela F, Roberto M . Transient abnormal myelopoiesis in Noonan syndrome. J Pediatr Hematol Oncol. 2002; 24(9):763-4. DOI: 10.1097/00043426-200212000-00017. View

15.

de Vries A, Stam R, Kratz C, Zenker M, Niemeyer C, van den Heuvel-Eibrink M . Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia. Haematologica. 2007; 92(11):1574-5. DOI: 10.3324/haematol.11493. View

16.

Balgobind B, Van Vlierberghe P, van den Ouweland A, Beverloo H, Terlouw-Kromosoeto J, van Wering E . Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood. 2008; 111(8):4322-8. DOI: 10.1182/blood-2007-06-095075. View

17.

Kratz C, Schubbert S, Bollag G, Niemeyer C, Shannon K, Zenker M . Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle. 2006; 5(15):1607-11. DOI: 10.4161/cc.5.15.3128. View

18.

Kotecha N, Flores N, Irish J, Simonds E, Sakai D, Archambeault S . Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell. 2008; 14(4):335-43. PMC: 2647559. DOI: 10.1016/j.ccr.2008.08.014. View

19.

Bader-Meunier B, Tchernia G, Mielot F, Fontaine J, Thomas C, Lyonnet S . Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr. 1997; 130(6):885-9. DOI: 10.1016/s0022-3476(97)70273-7. View

20.

Flotho C, Valcamonica S, Schmahl G, Corral L, Ritterbach J, Hasle H . RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia. 1999; 13(1):32-7. DOI: 10.1038/sj.leu.2401240. View